Rankings
▼
Calendar
ARCT Q1 2024 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
-59.4% YoY
Gross Profit
$33M
100.0% margin
Operating Income
-$30M
-93.3% margin
Net Income
-$27M
-82.3% margin
EPS (Diluted)
$-1.00
QoQ Revenue Growth
+30.0%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$419M
Total Liabilities
$155M
Stockholders' Equity
$264M
Cash & Equivalents
$288M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$33M
$80M
-59.4%
Gross Profit
$33M
$29M
+14.3%
Operating Income
-$30M
$15M
-306.1%
Net Income
-$27M
$51M
-152.8%
Revenue Segments
Collaboration Revenue
$33M
86%
Grant
$5M
14%
← FY 2024
All Quarters
Q2 2024 →